Hypotension action (α–2 agonists, beta-blockers, ACE inhibitors, MAO inhibitors, nitrates, sodium nitroprusside and hydralazine) |
Paradoxical arterial hypertension |
Antithrombotic action (argatroban, bezafibrate, heparin, salicylates, warfarin and clopidogrel) |
Rebound thromboembolism |
Antianginal action (nitrates, beta-blockers and calcium channel blockers) Antiarrhythmic action (adenosine, amiodarone, β-blockers, calcium channel blockers, disopyramide, flecainide, lidocaine, mexiletine, moricizine and procainamide) |
Paradoxical increase of frequency and/or intensity of angina pectoris |
Rebound exacerbation of basal arrhythmia after discontinuation or withdrawal of drug |
Pleiotropic (vasoprotective) action (statins) |
Anxiolytic action (barbiturates, benzodiazepines and carbamates) |
Paradoxical endothelial dysfunction Rebound anxiety |
Sedative-hypnotic action (barbiturates, benzodiazepines, morphine, promethazine and zopiclone) |
Paradoxical increased of agitation, nervousness, restlessness and irritability |
Antidepressant action (tricyclic, MAO inhibitors and selective serotonin reuptake inhibitors, |
Rebound increase of depressive symptoms |
Antipsychotic action (clozapine, phenothiazines, haloperidol and pimozide) |
Paradoxical exacerbation of psychotic manifestations |